- TheStreet.com•2 days ago
Emotion of yesterday's collapse is pretty much gone.
- Accesswire•7 days ago
NEW YORK, NY / ACCESSWIRE / March 17, 2017 / There has been significant interest in both companies by investment rating firms and individual investors over the past quarter. The interest is not necessarily ...
- GlobeNewswire•7 days ago
CAMBRIDGE, Mass., March 17, 2017-- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company focused on the discovery and development of unique RNA-targeted therapeutics for the treatment ...
SRPT : Summary for Sarepta Therapeutics, Inc. - Yahoo Finance
Sarepta Therapeutics, Inc. (SRPT)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||29.93 x 200|
|Ask||29.95 x 100|
|Day's Range||29.54 - 30.17|
|52 Week Range||8.00 - 63.73|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-5.45|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|